SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Bayer AG (BAYRY) , 前瞻盈利收益率 9.13%. PEG 0.92 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
- 前瞻市盈率 11.0
- PEG 比率 0.92 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
SharesGrow 综合评分： 32/100 其中 1/7 项标准通过。
SharesGrow 7-Criteria Score
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BAYRY
估值倍数
P/E (TTM)0.0
前瞻 P/E11.0
PEG 比率0.92
前瞻 PEG0.92
P/B 比率0.00
P/S 比率1.07
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.88
前瞻 EPS（预估）$1.09
每股账面价值$0.00
每股营收$11.14
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield9.13%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$1.36 |
$46.77B |
$4.53B |
9.7% |
| 2017 |
$2.07 |
$35.02B |
$7.34B |
21% |
| 2018 |
$0.45 |
$39.59B |
$1.7B |
4.3% |
| 2019 |
$0.62 |
$43.55B |
$2.43B |
5.6% |
| 2020 |
$-3.96 |
$41.4B |
$-15.56B |
-37.6% |
| 2021 |
$0.26 |
$44.08B |
$1B |
2.3% |
| 2022 |
$1.06 |
$50.74B |
$4.15B |
8.2% |
| 2023 |
$-0.75 |
$47.64B |
$-2.94B |
-6.2% |
| 2024 |
$-0.65 |
$46.61B |
$-2.55B |
-5.5% |
| 2025 |
$-0.88 |
$43.78B |
$-3.48B |
-7.9% |
